Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/day

BACKGROUND: The inhaled corticoteroid (ICS) ciclesonide (Cic), controls asthma symptoms in the majority of patients at the recommended dose of 160 µg/day. However, the relationship between the level of asthma control and increasing doses of Cic is unknown. This study investigated whether long-term t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Søren E, Prasad, Niyati, Goehring, Udo-Michael, Andersson, Henrik, Postma, Dirkje S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349703/
https://www.ncbi.nlm.nih.gov/pubmed/28331346
http://dx.doi.org/10.2147/JAA.S111712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349703/
https://www.ncbi.nlm.nih.gov/pubmed/28331346
http://dx.doi.org/10.2147/JAA.S111712

Ejemplares similares